Wednesday, December 17, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

SSR Mining Inc Shares Resume Trading Opportunities Await

Elaine Mendonca by Elaine Mendonca
February 13, 2024
in Breaking News
0
Mining Stock Market Today
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

SSR Mining Inc. shares are once again up for grabs! After a brief pause, the Canadian Investment Regulatory Organization (CIRO) has given the green light for trading to resume on the company’s stock. This exciting development was officially announced on February 13, 2024.

For those eager investors, SSR Mining Inc.’s stock can be found listed on the Toronto Stock Exchange under the symbol “SSRM”. If you’re curious about its performance and want to delve into the nitty-gritty details, financial news websites such as Yahoo Finance and The Globe and Mail are your go-to sources.

So, mark your calendars and get ready to dive into the world of SSR Mining Inc. shares, as they once again become available for trading. The stage is set, and the opportunities are boundless.

SSRM Stock Plummets 60.75% on February 13, 2024: Caution Advised for Investors

SSRM stock experienced a significant decline on February 13, 2024. The stock opened at $8.25, $1.47 lower than its previous close. SSRM is near the bottom of its 52-week range and trading below its 200-day simple moving average. The stock saw a sharp drop of $5.91, representing a 60.75% decrease. Investors should exercise caution when considering SSRM as an investment option. Thorough research and analysis should be conducted, and professional advice sought. Diversification is important to mitigate risk.

SSRM Stock Performance Analysis: Mixed Results on February 13, 2024

Title: SSRM Stock Performance Analysis: A Mixed Bag on February 13, 2024

Introduction:
On February 13, 2024, SSR Mining Inc. (SSRM) experienced a day of mixed stock performances. This article aims to delve deeper into SSRM’s financial performance, focusing on its total revenue, net income, and earnings per share (EPS) to provide a comprehensive analysis of the company’s stock performance on February 13, 2024.

Total Revenue:
SSRM’s total revenue for the past year amounted to $1.15 billion, marking a 22.12% decrease compared to the previous year. However, there was a positive trend in the most recent quarter, with total revenue reaching $385.39 million, reflecting a 28.03% increase since the previous quarter.

Net Income:
The net income for SSRM over the past year was $194.14 million, indicating a 47.26% decrease compared to the previous year. Similarly, during Q3, the net income decreased by 79.75% to $15.16 million.

Earnings per Share:
SSRM’s earnings per share (EPS) for the past year were $0.89, representing a 45.25% decrease compared to the previous year. The EPS for Q3 was reported at $0.07, reflecting a substantial 78.75% decrease since the previous quarter.

Conclusion:
SSRM’s stock performance on February 13, 2024, was marked by a mixed bag of results, influenced by the company’s financial performance. While the total revenue experienced a positive growth trend since the previous quarter, the year-on-year figures showed a decline. The net income and EPS figures also demonstrated a decrease since the previous year and quarter, indicating a decrease in profitability. These financial indicators likely played a role in shaping investor sentiment and the stock’s performance on the mentioned date. Investors and stakeholders should closely monitor SSRM’s financial performance to make informed decisions regarding their investment strategies moving forward.

Tags: SSRM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Exchange

Analysts Remain Positive on Workdays Outlook with Upgraded Ratings and Price Targets

The Remarkable Influence of Compounded Returns A Case Study of TakeTwo Interactive

Analyst Ratings and Price Target Adjustments for Blueprint Medicines

Recommended

Coinbase Stock

Coinbase Targets Australia’s $2.8 Trillion Pension Sector with New Crypto Offering

4 months ago
Voestalpine Stock

Voestalpine Shares: EU Policy Shift Reshapes Competitive Landscape

4 weeks ago
ANGL stock news

Hunter Perkins Capital Management LLC Makes Strategic Investment in AXIS Capital Holdings Limited

2 years ago
Biotechnology Market Capitalization

Oncolytics Biotech Exceeds Q4 Earnings Expectations

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Wall Street Analysts Favor Texas Roadhouse Amid Cost Relief Forecast

Viking Therapeutics: A Biotech Balancing Act Between Promise and Financial Pressure

Microsoft Shares Surge to Unprecedented Valuation

Meta Faces Dual Pressure: Product Innovation Meets Senate Scrutiny

IREN Shares Face Mounting Pressure Amid Strategic Concerns

OMV Shares Under Pressure Despite Strategic Black Sea Drilling Campaign

Trending

Quantum eMotion Stock
AI & Quantum Computing

Quantum eMotion Shares Gain Momentum on Strategic Cybersecurity Move

by Robert Sasse
December 17, 2025
0

Shares of Quantum eMotion have established a pronounced upward trajectory, fueled by a strategic expansion within the...

Rezolute Stock

Rezolute Shares Plummet Following Clinical Trial Failure

December 17, 2025
Comstock Stock

Comstock Shares Face Sustained Selling Pressure

December 17, 2025
Texas Roadhouse Stock

Wall Street Analysts Favor Texas Roadhouse Amid Cost Relief Forecast

December 17, 2025
Viking Therapeutics Stock

Viking Therapeutics: A Biotech Balancing Act Between Promise and Financial Pressure

December 17, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Quantum eMotion Shares Gain Momentum on Strategic Cybersecurity Move
  • Rezolute Shares Plummet Following Clinical Trial Failure
  • Comstock Shares Face Sustained Selling Pressure

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com